ArticleJournal of clinical microbiology2014
Impact of changes in Clostridium difficile testing practices on stool rejection policies and C. difficile positivity rates across multiple laboratories in the United States.
Article in Journal of clinical microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The emergence of Clostridium difficile infection in Asia: A systematic review and meta-analysis of incidence and impact.PloS one · 2017Pooled it
- Abundant geographical divergence of Clostridioides difficile infection in China: a prospective multicenter cross-sectional study.BMC infectious diseases · 2025Article
- Trends in Hospitalizations for Clostridioides difficile Infection in End-Stage Liver Disease, 2005-2014.Digestive diseases and sciences · 2021Article
- Heart Failure Is a Risk Factor for Suffering and Dying ofJournal of clinical medicine · 2020Article
- Article
- Epidemiology of Clostridium difficile infection in hospitalized adults and the first isolation of C. difficile PCR ribotype 027 in central China.BMC infectious diseases · 2019Article
- Preventable Patient Harm: a Multidisciplinary, Bundled Approach to Reducing Clostridium difficile Infections While Using a Glutamate Dehydrogenase/Toxin Immunochromatographic Assay/Nucleic Acid Amplification Test Diagnostic Algorithm.Journal of clinical microbiology · 2018Article
- Assessing the Burden of Clostridium difficile Infection in Low- and Middle-Income Countries.Journal of clinical microbiology · 2018Review
- Impact of the introduction of a nucleic acid amplification test forGut pathogens · 2018Article
- Clostridium difficile PCR Cycle Threshold Predicts Free Toxin.Journal of clinical microbiology · 2017Article
- Impact of a Healthcare Provider Educational Intervention on Frequency of Clostridium difficile Polymerase Chain Reaction Testing in Children: A Segmented Regression Analysis.Journal of the Pediatric Infectious Diseases Society · 2017Article
- Use of antibiotic and prevalence of antibiotic-associated diarrhoea in-patients with spinal cord injuries: a UK national spinal injury centre experience.Spinal cord · 2017Article
- Real-Time Electronic Tracking of Diarrheal Episodes and Laxative Therapy Enables Verification of Clostridium difficile Clinical Testing Criteria and Reduction of Clostridium difficile Infection Rates.Journal of clinical microbiology · 2017Article
- Infection prevention and control ofJournal of global health · 2016Review
- Community- and Healthcare-Associated Clostridium difficile Infections, Finland, 2008-2013Emerging infectious diseases · 2016Article
- Evaluating Epidemiology and Improving Surveillance of Infections Associated with Health Care, United States.Emerging infectious diseases · 2015Article
- Association Between Outpatient Antibiotic Prescribing Practices and Community-Associated Clostridium difficile Infection.Open forum infectious diseases · 2015Article
- Burden of Clostridium difficile infection in the United States.The New England journal of medicine · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We describe the adoption of nucleic acid amplification tests (NAAT) for Clostridium difficile diagnosis and their impact on stool rejection policies and C. difficile positivity rates. Of the laboratories with complete surveys, 51 (43%) reported using NAAT in 2011. Laboratories using NAAT had stricter rejection policies and increased positivity rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.